Разработка лекарств и открытый доступ: подходы и перспективы
Open Access
- 1 January 2018
- journal article
- Published by Doctrina, Ltd. in Microbiology Independent Research Journal (MIR Journal)
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Institutional profile: Community for Open Antimicrobial Drug Discovery – crowdsourcing new antibiotics and antifungalsFuture Science OA, 2017
- WONKAandOOMMPPAA: analysis of protein–ligand interaction data to direct structure-based drug designActa crystallographica. Section D, Structural biology, 2017
- Discovery of Potent and Selective Inhibitors for G9a-Like Protein (GLP) Lysine MethyltransferaseJournal of Medicinal Chemistry, 2017
- Open Targets: a platform for therapeutic target identification and validationNucleic Acids Research, 2016
- Chemical philanthropy: a path forward for antibiotic discovery?Future Medicinal Chemistry, 2016
- Open Access Could Transform Drug Discovery: A Case Study of JQ1Expert Opinion on Drug Discovery, 2016
- A community-based approach to new antibiotic discoveryNature Reviews Drug Discovery, 2015
- Open Access Target Validation Is a More Efficient Way to Accelerate Drug DiscoveryPLoS Biology, 2015
- Collaboration for rare disease drug discovery researchF1000Research, 2014
- Physicochemical Properties of Antibacterial Compounds: Implications for Drug DiscoveryJournal of Medicinal Chemistry, 2008